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ABSTRACT Silicified microcrystalline cellulose pellets with hydroxypropyl 
methylcellullose (HPMC) as modifier were prepared using a mixed solvent as liquid 
binder. Pellets were produced using extrusion-spheronization with a mixed solvent 
consisting of water and isopropanol as liquid binder. The key spheronization aid was 
Prosolv® SMCC 90. Low viscosity grade HPMC was incorporated aiming to modify 
release of indometacin. Physical characteristics including breaking load, apparent 
density and flow properties, particle size distribution and shape were determined. Drug 
loaded pellets were also tested for dissolution profiles. By adjusting liquid binder 
property, at isopropanol to water ratio of 3.5 to 6.5, pellets of desirable size and shape 
with reasonable yields were obtained. Pellets exhibited good flow property and they 
were mechanically strong. Pellet with higher HPMC content displayed a faster drug 
dissolution profile. This was because low viscosity grade HPMC was not enough to 
create strong gel. Instead hydration of HPMC molecules increased matrix’s 
hydrophilicity and weakened the structure of pellet faster. The release of indometacin 
was partly based on the erosion of hydrated matrix. The presence of HPMC in the 
pellets would require a mixed solvent to produce desirable shape. Incorporation of 
HPMC had modified drug release from the pellets without further coating. 
 
1. INTRODUCTION 
Extrusion-spheronization is a conventional technique to manufacture pellets. To form 
pellets by these techniques, microcrystalline cellulose (MCC) has been chosen as a 
spheronization aid as it can provide necessary plasticity to the wet mass1. As MCC 
pellets have limited disintegration, it retards drug release to some extent2. Conventional 
MCC such as Avicel PH101 has small size with relatively poor flow property3 while 
Prosolv® SMCC, a co-processed silicified MCC (SMCC) displays a better flow property4-
5. An optimal elasticity of Prosolv® SMCC based wet masses can be produced6 and 
Prosolv® SMCC 50 has been used as an alternative aid to produce round pellets7. 
Prosolv® SMCC 90 has been selected as the key spheronization aid which has not been 
studied. The mean size of Prosolv® SMCC 90 is doubled of SMCC® 504. As size of 
MCC is known to affect pellet properties8, this will be explored in this study. 
Hydroxypropyl methylcellulose (HPMC) is a type of cellulose ethers9. It has been used 
as a tablet binder, a thickener and a film former. Besides, it is one of the key excipients 
in the modified release delivery systems. HPMC E5 based matrix began to swell when 
immersed in the fluid and HPMC molecules were plasticized to form hydrogel at the 
outer surface of the matrix10. The resultant structural transformation had led to changes 
in drug concentration at interface of the medium and glassy matrix limiting drug release. 
Generally speaking, rate of drug release from such systems is governed by the 
properties of HPMC including composition of substituent groups and particle size. One 
of the interesting factors is the viscosity of HPMC. Matrices consisting of HPMC grade 
with low viscosity exhibited higher drug release than those with high viscosity. As low 
oral bioavailability of water insoluble drug is an issue, HPMC has also been used as a 
dissolution rate-enhancing polymer11. In our work, two different viscosity grades of 
HPMC will be used. They are HPMC 80-120cp13 and MethocelTM E15 LV (12-18cp for 
a 2% solution at 20oC)14. They are low molecular weight HMPC and are added to alter 
the properties of pellets and to modulate drug release. Water is the most common liquid 
binder employed in extrusion-spheronization and the effect of liquid binders on the MCC 
wet masses was studied15. As ethanol could not solvate MCC polar groups as water, 
ethanol molecules were readily removed by compression and produced wet mass with 
little cohesion. Because pellets were not successfully formed for water based HPMC 
wet mass, isopropanol (IPA), a class 3 solvent, has been used instead16. Water-IPA 
mixture is a solution as HPMC is insoluble in IPA, and has been used recently17. Pellets 
produced with organic solvents or mixed solvent systems possessed some non-
classical features of MCC pellets18-19. For example, pellets produced with 40% IPA in 
water as liquid binder gave a complete disintegration and rapid dissolution, while the 
use of 4.9mol% ethanol with water has resulted in pellets with no pore and dense 
surfaces20. Also the incorporation of HPMC has led to film rupture, which is not 
desirable17.Thus, the use of mixed solvents should be evaluated to reach the required 
attributes. Indomethacin (IND) is a non-steroidal anti-inflammatory drug (NSAID) with 
analgesic and anti-inflammation actions. The dosage forms present in the current 
market are suppositories and capsules where the modified release oral preparations 
were coated. However, the patients who take conventional forms of indometacin are 
more likely to experience its associated side effects. Thus, the development of 
sustained release pellets containing indometacin can be advantageous21. Indometacin 
is practically insoluble in water22. Emcompress® is a free flowing form of dibasic calcium 
phosphate dihydrate (DCP) that is non-hygroscopic23. It is used as a substitute to the 
drug in order to obtain the optimal formulation compositions and process conditions for 
pellet production before loading of drug. In summary, we will explore the feasibility of 
combining HPMC and Prosolv® SMCC 90 to prepare pellets by extrusion-
spheronization with the provision of these materials to modify dissolution profiles of 
indomethacin without the need of film coating. Our preliminary study will look at effect 
of altering ratios of IPA/water and pellet quantitative compositions which include amount 
and grades of HPMC, amount of silicified MCC (Prosolv® SMCC 90) and DCP (drug 
substitute to produce blank pellets). The pellet quality will be examined in terms of size 
distribution, sphericity, flow behavior, mechanical property and drug dissolution. We will 
prepare Prosolv® SMCC 50 pellets (as control) and compare their physical properties 
to those made from Prosolv® SMCC 90, the key spheronization aid used. By using a 
mixed solvent as the liquid binder, this will ease processing of pellets with HPMC by 
extrusion-spheronization. Also adding HPMC will change pellet properties including the 
drug release profile. 
 
2. MATERIALS AND METHODS 
2.1 Materials 
Prosolv® SMCC 50, Prosolv® SMCC 90 and dibasic calcium phosphate dihydrate 
(Emcompress®) were obtained from Mendell, Penwest Pharmaceutical Ltd. (Surrey, 
UK). Isopropanol, HPMC with viscosity of 80-120cp and indometacin were obtained 
from Sigma Aldrich Company Ltd. (Dorset, UK). MethocelTM E15 LV (abbreviated as 
HPMC 12-18cp) was obtained from Colorcon (Dartfort, UK). Water was freshly 
prepared distilled water. 
2.2 Production of pellets 
Pellets were produced with Prosolv® SMCC 90 and HPMC 80-120cp and DCP via 
extrusion-spheronization. Prosolv® SMCC 50 and MethocelTM E15 LV were also used 
as alternative aid and hydrophilic polymer, respectively. The optimal formulation 
compositions were loaded with 10% drug replacing DCP. Water or water-IPA was used 
as liquid binder. The suitable amounts of these dried ingredients were weighed (Precisa 
Balance Ltd., Dietikon, Switzerland). Total dried powder content for each batch was 
60g. The powders were pre-mixed using Turbula Mixer (TC-2, Willy A. Bachofen AG, 
Basel, Switzerland) for 3 minutes at 45rpm. Then, the mixture was mixed in the 
planetary mixer (Model A901E, Kenwood Chef, UK) for 8 minutes with the speed setting 
of 3 and an appropriate amount of liquid binder which was almost equal to the amount 
of silicified MCC was added. Then the wet mass was extruded immediately with a radial 
extruder (Model 20 Extruder, Caleva Ltd, UK) that was fitted with a screen of 150mm in 
diameter and 1.0mm die holes. The extruder screen rotated at 30rpm. After storing the 
extrudates in an air-tight container for 15 minutes, the sample was spheronized for 10 
minutes (Model 120GB spheronizer, Caleva Ltd., UK) that was fitted with a 125mm 
cross-hatch frictional plate. Spheronization speed for screening purpose was been 
adjusted from 800 to 3000rpm. Ultimately, the remaining formulations were spheronized 
at 3000rpm. Pellets were collected and left to dry at 40oC oven until constant mass had 
reached. Table 1 listed the compositions of pellets. 
2.3 Particle size distribution 
Sieve analysis was conducted to assess size distribution of the pellets. A stack of British 
Standard sieves of √2 progression between 0.212 and 2.00mm was used. The pellets 
were poured into the top sieve and they were vibrated for 10 minutes using a sieve 
shaker (Model: EFL 2000, Endecotts Ltd., UK). After the shaking has completed, the 
mass of each sieve with retained pellets was determined in order to calculate the 
percentage of pellets retained of each sieve before constructing the frequency 
distribution. The percentages of coarse (>1.4mm) and fine fractions (<0.50mm) of the 
pellets were determined. According to the cumulative percentage size distribution curve 
constructed, the median diameter (D50) and the interquartile range (IQR) were 
determined. IQR was determined by subtracting the sizes at the 75% cumulative 
frequency to the 25% cumulative frequency. The percentage yield was calculated 
based on the sum of pellet sizes between 0.5 and 1.4mm. 
2.4 Pellet shape 
An image analysis system (KS 400 version 3.0, Carl Zeiss Vision GmbH, Germany) 
was used to determine the 2D shape of pellets. Thirty pellets were randomly selected 
(sieve fraction: 0.71-1.0mm) for analysis. Pellets were placed under a pre-calibrated 
microscope (Leitz Dialux 22, Ernest Leitz Wetzlar GmbH, Germany) that was attached 
to a digital camera (AxioCam MRC5, Carl Zeiss Vision GmbH, Germany) for capturing 
images of pellets. Feret diameters, circularity (Fc), aspect ratio (AR), projected area 
and perimeter were directly derived by the image analysis software and by using 
appropriate formulas as describedl24. 
2.5 Particle morphology by scanning electron microscope 
Morphology and surface texture of pellets (sieve fraction: 0.71-1.0mm) were inspected 
using a scanning electron microscopy (SEM) (Hitachi S3000N, Hitachi High 
Technologies America Inc., Pleasanton, CA). Pellets were placed on a 15mm double-
sided carbon adhesive aluminium specimen stub (Agar Scientific, Essex, UK). The 
specimens were then coated with palladium and gold under argon atmosphere by a 
sputter coater (model SC7620, Quorum technologies, UK) with a processing current of 
18-20mA for 2x105s as described25. The raw materials were also examined. 
2.6 Flowability of pellets 
Approximately 6g of pellets (sieve size: 0.71-1.0mm) were poured into a measuring 
cylinder without any vibration to determine the maximum bulk volume (Vb) of pellets. 
Volume readings after each 10 taps interval were recorded till the difference in tapped 
volume and the last volume reading was not changed by over 1ml. This is regarded 
as minimum bulk volume (Vt) of the pellets. In this study, around 80 taps were 
required to reach Vt. The bulk density (ρbulk) and tapped density (ρtapped) were 
calculated by dividing mass of the sample by Vb and Vt, respectively, for each sample. 
Carr’s Compressibility Index (CI) and Hausner Ratio (HR) can be calculated according 
to the equations stated in British Pharmacopoeia (BP)26 and presented below,  
CI (%) = [(ρtapped-ρbulk)/ρtapped] x 100% 
HR = ρtapped /ρbulk 
Flow properties of the samples could then the described based on the scale of 
flowability as described26. The same procedure was applied to raw powder materials. 
The experiment was conducted twice for each specimen. 
2.7 Apparent density 
The apparent density of pellets (sieve fraction: 0.71-1.0mm) was measured in duplicate 
using a helium multi-pycnometer (Quantachrome Instruments, Boynton Beach, USA). 
Initially, the equipment was calibrated using standard steel balls to determine the 
reference volume (VR) and the total volume of the system (VC). Then, a known weight 
of pellets was placed in a microcell-sample holder. The system was connected to helium 
gas that functioned in removing any gas adsorbed on the pellet surface. The pressure 
of a fixed amount of gas in the reference (P1) and pressure of a fixed amount of gas in 
sample cell (P2) were recorded. The apparent volume of pellet (Vp) was determined 
using the equation as shown below, 
Vp = Vc - VR ((P1/P2)-1) 
The apparent density of pellets was calculated by dividing the sample mass by Vp 
value. The density measurements were repeated for the raw ingredients. 
2.8 Pellet tensile strength 
The mechanical testing instrument (CT-5 Engineering System, Nottingham, UK) was 
fitted with a 5kN load cell and the speed of the upper platen was set at 1mm.min-1. The 
force that was used to break each pellet was obtained. Twenty randomly selected 
pellets (sieve size: 0.71-1.0mm) were used. 
2.9 Calibration curve for indometacin 
Indometacin powder was dissolved in phosphate buffer solution pH 7.2 to prepare a 
500µg.mL-1 stock solution. The stock solution was diluted with the same buffer to 
prepare calibration solutions ranging from 5 to 75µg.ml-1. The drug absorbance values 
were determined at 320nm using a UV spectrophotometer (CamSpec, UK). A good 
linearity was obtained with R2=0.9949. The calibration equation was, absorbance = 
0.0195 X Concentration (µg.ml-1) and was used for further analysis. 
2.10 Drug content determination and In vitro release profile and  
 
For drug content uniformity test, 100mg of pellets were crushed and drug particles were 
dissolved in phosphate buffer pH 7.2. The samples were then diluted to a target 
concentration of 50ug.ml-1 before UV monitoring. Triplicate for each batch was used.       
Dissolution study of drug loaded pellets was performed using the BP dissolution 
Apparatus II (Erweka® GmbH, Germany) and in accordance to the conditions described 
in British Pharmacopoeia27. IND loaded pellets (equal to 75mg of drug) were placed in 
each dissolution vessel containing 900ml phosphate buffer pH 7.2, maintained at 37oC. 
The paddles were rotated at 50rpm. Ten microliters of samples were withdrawn at the 
intervals of 10, 20, 30, 40, 50, 60, 120, 180, 240, 300, 360, 420 and 480 minutes. 
Following each withdrawal, a 10ml of buffer solution was immediately replaced. The 
drug absorbance values of each sample were determined at 320nm using UV-visible 
spectrophotometer (CamSpec, UK). The experiment was performed in triplicate.  
2.11 Statistical analysis 
Statistical analysis was performed using SPSS software (version 23.0, SPSS Inc. 
Chicago, USA). Data were compared by using one-way ANOVA where applicable and 
followed by a post hoc test. A p-value of less than 0.05 was considered as significant. 
 
3. RESULTS AND DISCUSSIONS 
Extrudates were found to be typically long and cylindrical in appearance with smooth 
surfaces. The overall yield after extrusion was roughly 70% for batches with and without 
drug. Hence, the lost during extrusion step was the highest. This was partly due to the 
fact that materials stuck to the extrusion rotor as well as lost due to sample transfer. 
3.1 Pellet size and shape 
In our preliminary work, when water or when 80% and over of water in the mixed solvent 
system was used, extrudates could not be rounded and the yields of the pellets were 
low for formulations consisting of HPMC, Prosolv® SMCC 90 and DCP (data not 
presented). Reasonable pellet yields were obtained when IPA content in the liquid 
binder was further increased. The modal class of these pellets was mainly found in 
0.71-1.0mm as the die hole for extruder screen is 1.0mm. Despite using a mixed solvent 
system, the optimal ratio of liquid binder to spheronization aid was found to be similar 
to those produced with water for Prosolv® SMCC 50 based pellets7. 
For blank pellets, except for A1 and A2, all other pellets recorded <10% fine or coarse 
fractions indicating the amount of liquid binder used was at appropriate level. The typical 
IQR ranged 0.18-0.25mm and this is similar to our previous studies7, 25. Based on Table 
1, except for A1, A2-A4 where decreasing proportion of water was employed (3/7, 
3.5/6.5, 4/6 of IPA/water), median diameters of the pellets were only increased slightly 
indicating there was a modest pellet growth while there was an increase in the yields. 
This has showed that mixed solvent eased the production of pellets. Apart from particle 
growth to the expected size, shape is an important characteristic for pellet. An ideal 
shape of pellet should have an aspect ratio <1.2 and a circularity (Fc) value close to 
1.028. The pellets adhered to these criteria when mixed solvent system was kept at 
3.5/6.5 of IPA/water (Figure 1). Hence, for the remaining work, this ratio was used. By 
keeping HPMC 80-120cp content at 10%, there is no remarkable difference in terms of 
median diameters and aspect ratios among the pellets of A5, A6 and A3 with a 2.5% 
increment of DCP from 5 to 10%. While comparing the two grades of silicified MCC, B1 
and B2 that consisted of 85% and 80% Prosolv® SMCC 50 at 10% DCP, they had 
smaller aspect ratio values than those made with Prosolv® SMCC 90 of the similar 
compositions, i.e. A3 and A7, where the aspect ratio values were 1.1-1.12 and 1.14-
1.16, respectively. Thus, despite its larger particle size, Prosolv® SMCC 90 has limited 
effect on shape of the pellet when manufactured at the right conditions. Pellet 
roundness reduced with an increase in HPMC viscosity29. Pellets at 80% Prosolv® 
SMCC 90, 10% DCP were compared for HPMC viscosity effect. C1, which was 
produced with HPMC 12-18cp (at 10%), possessed a larger size than A3 due to use of 
slightly higher level of liquid binder. It has an aspect ratio of 1.12. When HPMC 12-18cp 
content was increased to 20% by keeping DCP level constant, aspect ratio increased 
to 1.2 without growth of pellet size (D50 value of C2=0.87mm). This showed that a lower 
percentage of HPMC and higher percentage of silicified MCC produced rounder pellets. 
Increasing HPMC level made it harder to round off the extrudates regardless of the 
HPMC viscosity. For drug loaded pellets, decreasing Prosolv® SMCC 90 content and 
with a small reduction in the amount of liquid binder as in D2 had also produced smaller 
median diameter corresponding to those without drug. Despite applying the maximum 
spheronization speed and extending residence time beyond 10 minutes, we observed 
no further size growth. HPMC was not pre-dissolved as part of the liquid binder instead 
it was added directly as part of pellet matrix. Unlike MCC that acts like a sponge, HPMC 
particles swell and dissolve gradually in the liquid binder and increase tackiness of 
extrudates making them harder to spheronize and for materials to transfer. In summary, 
whether the extrudates can be rounded off directly, or broken down initially and then re-
grow to the required size and shape depend on formulation compositions, nature of 
liquid binder and process conditions. Compaction of wet mass into extrudates is 
strongly influenced by the water sorption on MCC. Structural re-arrangement of HPMC 
on exposure to water is anticipated and this leads to viscous gel formation that changes 
rheological property of the wet mass. Moreover, wetting of whole powder blend can be 
retarded and less even fluid distribution occurs as HPMC gel layer acts as retardant for 
fluid penetration. This has led to formation of lumpy agglomerates that is difficult to 
handle30. Isopropanol has no such effect and suppressed HPMC hydration. Thus the 
presence of IPA can improve consistency of the wet mass containing HPMC. Sphericity 
of pellets was improved as IPA ratio is increased in liquid binder (Figure 1). Water is 
still needed for many reasons including as a plasticizer and a lubricant. It also maintains 
cohesive strength for shaping of extrudates into pellets25. 
3.2 Powder and pellet flow property 
Cohesiveness of powder can be indicated by Hausner ratio (HR) where values between 
1.25 and 1.4 are considered having an intermediate flow with some cohesive properties. 
Meanwhile, Carr’s compressibility index (CI) is a direct measure of potential powder 
arch or bridge strength. CI has been related to material flow and is dependent on the 
measured bulk and tapped density values31. Powders are typical free flowing when their 
sizes are larger than 250µm and become cohesive and experience flow issue when the 
sizes fall below 100µm32. Based on scale of flowability26, DCP, HPMC 80-120cp and 
IND possessed poor flow (Figure 1). This is because these powders are small in size 
and have a relatively high surface area to volume ratio and inter-particulate forces are 
dominating leading to poor flow. SEM images confirmed that powder excipients and 
IND were fine and had irregular shapes with rough surfaces (Figures 2a-f). CI and HR 
values of the pellets were less than 10% and 1.1, respectively, regardless of type of 
spheronization aids. There was little correlation between aspect ratio and CI or HR 
value of Prosolv® SMCC 90 based pellets (R2=0.23-0.25). Thus size enlargement is the 
key factor that the pellets having better flow than the respective powders. 
3.3 Apparent density by helium pcynometer 
Size and shape of raw materials as well as packing of the materials upon processing 
affect density and hence porosity of pellets. Based on results above, A1, which was the 
least spherical in shape and with the largest in median diameter has the highest 
apparent density compared to those pellets made with lower water ratios in liquid binder 
(A2-A4, Figure 3). This is unexpected because the least spherical and larger size tends 
to be more porous and thus having a lower density. As the liquid binder was made of 
80% water for A1, a greater extent of HPMC gelling was anticipated to strengthen 
particle binding. The apparent densities of other pellets were similar ranging 1.51-
1.59g.cm-3 indicating the compaction of the pellets were of similar degrees as they were 
processed using the same conditions. The density of pellets loaded with drug also fell 
within the lower end of this range as indometacin has a smaller true density than DCP. 
C2 made with 20% HPMC 12-18cp exhibited the lowest apparent density, partly due to 
the fact that the extrudates could not be rounded off and it was made of the highest 
quantity of HPMC that possessed lower true density. 
3.4 Breaking load of pellet 
The pellets produced using silicified MCC with addition of HPMC had good mechanical 
strength (Figure 3). A1 required a higher breaking load than A2-A4, as it was prepared 
with a binder with a higher ratio of water where a larger number of liquid bridges formed 
that enabled more particles interacted after process manipulation18. Higher HPMC 
content led to mechanically stronger pellets in their dried forms supporting previous 
observations17. Pellets that were made of higher silicified MCC but lower HPMC content 
(D1, A7 and B1) exhibited lowered breaking loads. Increasing the amount of HPMC led 
to mechanically stronger pellets in their dried forms due to creation of gel structure that 
give better bonding amongst other powder particles (Figure 3). For drug loaded pellet, 
unlike D1 where pellets were completely crushed under applied force, this was not seen 
with D2, which meant the pellets were more rigid in nature. The breaking loads of A3 
was higher than C1 as a higher viscosity HPMC 80-120cp was used that could link with 
creation of thicker gel layers that form around particles. By increasing the low viscosity 
grade HPMC 12-18cp to 20%, the breaking load increased as seen in C2. These results 
support the idea that HPMC viscosity and composition are the key factors governing 
crushing strength of pellet. Based one One-way ANOVA, only pellets with mean 
breaking load values <7N were found to be significantly smaller than A1 (p<0.05). It has 
been previously showed that apparent pellet density is linked to its mechanical 
strength33. Figure 4 showed the breaking loads of pellets are related to the apparent 
density of pellets while the effect of size was less prominent based on the evaluation 
using D50 values. As size increases while density remains similar, surface area to 
volume ratio will be smaller. Thus interactions amongst particles reduced and these 
pellets will require smaller force to be deformed. It was not apparent in our case as R2 
was small because D50 of pellets were similar ranging 0.82-0.97mm. 
3.5 Drug content uniformity test and In vitro release study 
Pellets conformed to the BP drug content uniformity (target: 90-110%). The drug 
content for D1 was 96.4- 98.4% and D2 was 92.6-95.4%. The pellets exhibited modified 
release profiles where drug release was faster during the first few hours and then 
became more gradual (Figure 5). Indometacin has a pKa value of 4.534, it ionizes in the 
medium with higher pH, and high fraction of ionized species is expected at pH 7.2. Drug 
release was retarded as IND particles were packed within the pellet matrix. Only when 
the matrix is hydrated, drug dissolution occurs. Dissolved drug molecules are released 
from the pellets by various mechanisms, including diffusion via the swollen matrix layer 
and/or via matrix erosion due to weakened gel layer. A study has shown that there were 
immediate and steady drug release for MCC and HPMC based tablets, respectively35. 
This was because hydration of MCC differs from HPMC. Water molecules were trapped 
within the MCC sponge to induce local swelling of matrix36 meanwhile a regular 
hydration was seen in Methocel E15LV granules as fully amorphous HPMC allowed 
greater water mobility to occur than MCC35. At the end of 8th hour, D1 and D2 gave 
approximately 55% and 90% drug release, respectively. Dissolution profiles of the 
pellets were compared after calculating the similarity index (F2) value, and the 
dissolution profiles differ with the F2 value of 28.3%37. The pellet dissolution profiles 
were further analyzed for the best fitted kinetic models38. From our analysis, D1 is best 
described with Higuchi model (R2=0.9966) while D2 adhered best to Kosmeyer-Peppas 
(KS) model (R2=0.9915). However D1 also fitted to KS model (R2=0.9922). The 
diffusional exponent (n) values for D1 and D2 based on based on KS model were 0.65 
and 0.86, respectively, indicated a non-Fickian or anomalous transport (0.45<n<0.89) 
for the drug release mechanism38. As expected with our pellets, applying low viscosity 
grade HPMC produces gel with less resistance to mechanical stresses that tends to 
dissolve faster and erodes more rapidly also we limited the HPMC content up to 10%39. 
A faster dissolution rate of D2 can be further explained as higher HPMC content 
increased wettability of insoluble drugs or matrix that has resulted in higher and faster 
medium uptake into the pellets due to formation of more pores or water channels21. 
Larger pores were seen on the surface of pellets after dissolution test (Figures 2i-j) 
compared to those before the test (Figures 2g-h). This indicated that drug release and 
matrix erosion had occurred. Meanwhile, signs of fragmentation were observed in D2 
supporting that more drug was released as the gel formed could not be held together. 
 
4. CONCLUSIONS 
Water is normally used as the liquid binder in extrusion and spheronization. However, 
with addition of HPMC to the pellet, it is not ideal. Instead, combination of organic 
solvent with water is successful to act as liquid binder for hydrophilic matrix component. 
The optimal water to IPA ratio that can be used to produce pellets is 6.5 to 3.5 without 
compromising key pellet properties including size distribution, shape and mechanical 
property. Prosolv® SMCC 90 based pellets with low viscosity HPMC grades have good 
flow property despite higher aspect ratios, and high yield is obtained. Their mechanical 
strengths were comparable to Prosolv® SMCC 50 based pellets. The presence of low 
quantity of HPMC 80-120cp up to 10% altered the release of indometacin from the 
pellets. More HPMC and less silicified MCC increased the overall drug release. This is 
based on faster wetting of compact with limited gel formation. In summary, we produced 
indometacin loaded pellets using HPMC as modifier and Prosolv® SMCC 90 as key 
spheronization aid while employing mixed solvent consisting IPA/water that had 
enabled the manufacture of modified release pellet formulation.  
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Table 1 Formulation compositions, size distribution and yield values of the pellets. 
a Indicates Prosolv® used was SMCC 50, and the remaining pellets used SMCC 90. 
b Indicates MethocelTM E15 LV was used, the remaining pellets used HPMC 80-120 cp 
c Percentage of liquid binder was calculated based on total dried powder mass. 

























A1 10 80 10 80.1 8:2 0.97 0.42 81.69 0.00 18.31 
A2 10 80 10 65.2 7:3 0.78 0.24 89.43 10.57 0.00 
A3 10 80 10 75.4 6.5:3.5 0.82 0.18 95.60 4.84 0.00 
A4 10 80 10 71.9 6:4 0.85 0.18 94.98 5.02 0.00 
A5 5 85 10 81.3 6.5:3.5 0.85 0.18 97.76 2.24 0.00 
A6 7.5 82.5 10 78.2 6.5:3.5 0.85 0.18 99.23 0.77 0.00 
A7 10 85 5 81.9 6.5:3.5 0.89 0.18 99.38 0.62 0.00 
B1 10 85a 5 82.3 6.5:3.5 0.86 0.17 98.65 1.35 0.00 
B2 10 80a 10 79.1 6.5:3.5 1.01 0.25 96.93 3.07 0.00 
C1 10 80 10b 79.8 6.5:3.5 0.97 0.20 99.03 0.00 0.97 
C2 10 70 20b 70.6 6.5:3.5 0.87 0.18 98.70 0.47 0.80 
D1 10d 85 5 80.1 6.5:3.5 1.01 0.25 97.64 2.35 0.00 
D2 10d 80 10 78.4 6.5:3.5 0.81 0.24 94.78 2.78 2.44 
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Figure 1 Flow properties and shape parameters of pellets and raw materials. The 
flow properties were Carr’s compressibility index (CI, represented by line) and 
Hausner ratio (HR, grey bars) values and the shape parameters were aspect ratio 
(AR, white bars) and circularity (Fc, black bars) values. Bars and symbol on line 
represent mean values. 
 
Figure 2 SEM images of raw materials and IND loaded pellets before and after 
dissolution tests at different resolutions. (a) HPMC 12-18cp, (b) HPMC 80-120cp,  
(c) DCP,(d) Prosolv® SMCC 50, (e) Prosolv® SMCC 90, (f) IND; (g1-3)  D1 pellets 
before dissolution test; (h1-3) D2 pellets before dissolution test; (i1-3) D1 pellets 
after dissolution test; (j1-3) D2 pellets after dissolution test. Similar morphology 
was observed for blank pellets (images not inserted). 
 
Figure 3 Density for raw materials and pellets as determined by pcynometer (solid 
bars) and breaking load values of pellets (open bars). Bars represent mean values. 
 
Figure 4 Relationship between breaking loads and median diameters (D50) or apparent 
density of pellets made with HPMC 80-120cp, Prosolv® SMCC 90 and DCP of 
various compositions (A1 –A7). 
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Figure 2 SEM images of raw materials and IND loaded pellets before and after 
dissolution tests at different resolutions. (a) HPMC 12-18cp, (b) HPMC 80-120cp,  
(c) DCP,(d) Prosolv® SMCC 50, (e) Prosolv® SMCC 90, (f) IND; (g1-3)  D1 pellets 
before dissolution test; (h1-3) D2 pellets before dissolution test; (i1-3) D1 pellets 
after dissolution test; (j1-3) D2 pellets after dissolution test. Similar morphology was 
observed for blank pellets (images not inserted).  
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Figure 4 Relationship between breaking loads and median diameters (D50) or 
apparent density of pellets made with HPMC 80-120cp, Prosolv® SMCC 90 and 




























Figure 5 In vitro release profiles of IND loaded pellets. 
  
 
 
 
 
